Steroid Sparing Regimen With Olanzapine and Palonosetron for Emetic Prevention for High Dose Cisplatin

Clinical trial NCT07699276 · RECRUITING

Trial details

NCT number: NCT07699276
Sponsor: Mahidol University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cancer (Solid Tumors)Vomiting Cisplatin Olanzapine

Start date: 2026-02-10
Primary completion: 2027-10-01
Enrollment: 95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.